ALECENSA gél 150 mg 224 pce
7680659700013
CH-65970
L01ED03
07.16.1.
Reimbursement limitations:
ALECEN.NSCLC
Traitement du CPNPC localement avancé ou métastatique
Après accord sur la prise en charge des …
1 / 3
google
Details
- Product number
- 6597001
- CPT
- -
- Packaging group
- 224
- Unit
- Kapsel(n)
- Composition
- alectinibum 150 mg ut alectinibi hydrochloridum, lactosum monohydricum 33.67 mg, hydroxypropylcellulosum, natrii laurilsulfas corresp. natrium 6 mg, carmellosum calcicum, magnesii stearas, Kapselhülle: carrageenanum, kalii chloridum, E 171, cera carnauba, maydis amylum, hypromellosum, Drucktinte: E 172 (rubrum), E 172 (flavum), E 132, cera carnauba, lacca, polyglyceroli-3 mono-oleas, pro capsula.
Articles (1)
Alecensa 150 mg, Hartkapseln
Kapseln
224
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
33.67 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
6.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 4741.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2017
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 65970
- Drug name
- Alecensa, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L01ED03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 26/01/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ALECENSA gél 150 mg 224 pce
- Description (DE)
- ALECENSA Kaps 150 mg 224 Stk
- Market launch
- 26/01/2017
- Narcotic (BTM)
- No